Low contralateral neck recurrence risk with ipsilateral neck radiotherapy in N2b tonsillar squamous cell carcinoma.
暂无分享,去创建一个
[1] A. Garden,et al. Unilateral Radiotherapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papilloma Virus (HPV), Positron-emission Tomography (PET) and Intensity-modulated Radiation Therapy (IMRT). , 2022, International journal of radiation oncology, biology, physics.
[2] Steven S. Chang,et al. Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary , 2020, Head & neck.
[3] T. Roques,et al. Ipsilateral neck radiotherapy in N2b well‐lateralized tonsil cancer – Approach with caution , 2019, Head & neck.
[4] J. Kazmierska,et al. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] W. Thorstad,et al. Comparison of unilateral versus bilateral intensity‐modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil , 2017, Cancer.
[6] J. Waldron,et al. Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Waldron,et al. Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later. , 2017, International journal of radiation oncology, biology, physics.
[8] M. Urken,et al. Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization , 2017, Head & neck.
[9] Sang‐wook Lee,et al. Comparison of the Clinical Outcomes of Patients with Squamous Cell Carcinoma of the Tonsil Receiving Postoperative Ipsilateral Versus Bilateral Neck Radiotherapy: A Propensity Score Matching Analysis (KROG 11-07) , 2017, Cancer research and treatment : official journal of Korean Cancer Association.
[10] F. Alongi,et al. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist. , 2016, The British journal of radiology.
[11] W. Mendenhall,et al. Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil , 2016, European Archives of Oto-Rhino-Laryngology.
[12] S. Bhide,et al. Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. , 2014, Oral oncology.
[13] Joshua D. Lawson,et al. ACR appropriateness criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil , 2012, Head & neck.
[14] B. Panizza,et al. Results of a prospective study of positron emission tomography–directed management of residual nodal abnormalities in node‐positive head and neck cancer after definitive radiotherapy with or without systemic therapy , 2011, Head & neck.
[15] C. Grau,et al. Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] P. Levendag,et al. Unilateral neck irradiation for well-lateralized oropharyngeal cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.